This chapter will be broken into several sections. The first section will be an outline of the neurophysiology of three separate psychedelic drugs: Ayahuasca or N,N-dimethyltryptamine (DMT); Lysergic acid diethylamide (LSD); and Psilocybin (Shrooms). Next it will outline a basic synthesis of the key neurological outcomes across those three substances that will allow SABCIs to mimic their neurophysiological effects. Finally, this chapter will construct a computational ethical framework for the production and distribution of emergent SABCIs as a potential template for equitably distributing emergent technologies.